COMP <GO>
ITGR vs ABBV // FORWARD P/E MULTIPLE
Integer Holdings Corporation (NYSE) VS. AbbVie Inc. (NYSE) • 15-METRIC TALLY: ITGR 3
— ABBV 11
▲ FORWARD P/E MULTIPLE LEADER: ITGR
LAST: $126.59 (+0.06%) • MKT CAP: $4.30B
forward-pe
38.9x
LAST: $294.89 (+1.41%) • MKT CAP: $513.86B
forward-pe
113.1x
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (ITGR VS. ABBV)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | ITGR | ABBV | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 27.00% | 70.20% | -43.20 | ABBV | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 6.00% | 29.00% | -23.00 | ABBV | /roic <GO> |
| EV/EBITDA & P/E Valuation | 18.3x | 33.3x | -15.00 | ITGR | /valuation <GO> |
| Free Cash Flow Yield | 2.44% | 3.47% | -1.03 | ABBV | /fcf-yield <GO> |
| Operating Margin | 11.90% | 24.60% | -12.70 | ABBV | /operating-margins <GO> |
| Net Profit Margin | 5.50% | 6.90% | -1.40 | ABBV | /net-margins <GO> |
| Revenue Growth (YoY) | 8.00% | 8.60% | -0.60 | ABBV | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 2.27% | -2.27 | ABBV | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 2.91 | 5.33 | -2.42 | ABBV | /balance-sheet <GO> |
| Piotroski F-Score Quality | 7/9 | 7/9 | 0.00 | TIE | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew | 7.00% | 7.40% | -0.40 | ITGR | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 62.2 | 72.8 | -10.58 | ABBV | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 1.02 | 1.15 | -0.13 | ABBV | /macro-sensitivity <GO> |
| Forward P/E Multiple ACTIVE | 38.9x | 113.1x | -74.20 | ITGR | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $4.30B | $513.86B | -$509.56B | ABBV | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | ITGR REV | ABBV REV | ITGR GROSS % | ABBV GROSS % | ITGR FCF | ABBV FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.85B | $61.16B | 27.0% | 70.2% | $105.1M | $17.82B |
| FY 2024 | $1.72B | $56.33B | 26.7% | 70.0% | $99.8M | $17.83B |
| FY 2023 | $1.56B | $54.32B | 44.0% | 44.0% | $110.2M | $20.39B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
ITGR // BETA 1.02
ABBV // BETA 1.15